Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration

European Journal of Paediatric Neurology

Volumn 13, Issue 1, 2009, Pages 61-64

  Mikati, Mohamad A ^a   Yehya, Amin ^a   Darwish, Houssein ^a   Karam, Pascale ^a   Comair, Youssef ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Deep brain stimulation (DBS); Generalized dystonia; Hallervorden spatz syndrome.; Neurodegeneration with brain iron accumulation (NBIA); Pantothenate kinase 2 gene (PANK2)

Indexed keywords

ALANINE; AMINO ACID; BACLOFEN; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; DIAZEPAM; PANTOTHENATE KINASE 2; PHENYTOIN; TRIHEXYPHENIDYL; VALINE;

ARTICLE; ATAXIA; BRAIN; BRAIN DEPTH STIMULATION; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE REMOVAL; DISEASE ACTIVITY; DISEASE SEVERITY; DYSTONIA; EXON; FEMALE; GENE MUTATION; GIRL; GLOBUS PALLIDUS; HUMAN; INFECTION; MOTOR CONTROL; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEIZURE; SPEECH; SYMPTOM; TONIC CLONIC SEIZURE;

ATAXIA; CHILD; DEEP BRAIN STIMULATION; DYSTONIA; FEMALE; HUMANS; MOTOR SKILLS; MUTATION, MISSENSE; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPEECH; TREATMENT OUTCOME;

EID: 57449099943     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2008.01.006     Document Type: Article

References (13)

1. Zhou B., Westaway S.K., and Levinson B. A novel Pantothenate kinase gene (PANK2) is defective in Hallervorden Spatz syndrome. Nat Genet 28 (2001) 345
2. Magarinos-Ascone C.M., Regidor I., Martinz-Castrillo J.C., Gomez-Galan M., and Figueiras-Mendez R. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 76 7 (2005) 904
3. Sharma M.C., Aggarwal N., Bihari M., Goyal V., Gaikwed S., Vaishya S., et al. Hallervorden spatz disease: MR and pathological findings of a rare case. Neurol India 53 (2005) 102-104
4. Umemura A., Jaggi J.L., Dolinskas C.A., Stern M.B., and Baltuch G.H. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. J Neurosurg 100 4 (2004) 706
5. Barry M.J., VanSwearingen J.M., and Albright A.L. Reliability and responsiveness of the Barry-Albright dystonia scale. Dev Med Child Neurol 41 (1999) 404-411
6. Wong V., Wong S., Chan K., and Wong W. Functional independence measure (WeeFIM) for Chinese children: Hong Kong cohort. Pediatrics 109 2 (2002) 36
7. Hayflick S.J., Westaway S.K., and Levinson B. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348 (2003) 33
8. Swaiman K.F. Hallervorden-spatz syndrome. In: Goldstein G.W., and Waxman S.J. (Eds). Neurobase. 4th ed (1998), Arbot Publications, San Deigo
9. Koyama M., and Yagishita A. Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow. Am J Neuroradiol 27 (2006) 212-213
10. Krause M., Fogel W., and Tronnier V. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 21 (2005) 2255-2257
11. Thomas M., Hayflick S.J., and Jancovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz Syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 19 1 (2004) 36-42
12. Vitek J.L., Chockkan V., and Zhang J.Y. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 46 (1999) 22-35
13. Castelnau P., Cif L., Valente E.M., Vayssiere N., Hemm S., Gannau A., et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 57 (2005) 738-741